Susan G. Komen®, the world’s main breast most cancers group, is awarding $21.7 million to fund 48 new analysis initiatives at 26 distinguished educational medical establishments within the U.S. which can be centered on bettering affected person outcomes – significantly for individuals with essentially the most aggressive breast cancers, or who’ve skilled a recurrence or metastasis. With this funding, Komen is now supporting greater than 152 energetic analysis initiatives representing greater than $115 million in funding.
The funding we’re saying right now in a broad portfolio of cutting-edge analysis will assist advance breast most cancers care and enhance outcomes for all individuals recognized with breast most cancers, together with underserved populations and people with few therapy choices. With this funding, we’re supporting among the high breast most cancers researchers who share our mission and giving everybody impacted by breast most cancers hope, as we transfer nearer to the cures for breast cancers.”
Victoria Wolodzko Good, SVP of Mission at Susan G. Komen
Of the entire $21.7 million awarded right now:
- 79 p.c helps analysis centered on essentially the most aggressive breast cancers, metastasis and recurrence;
- 33 p.c helps medical trials;
- 20 p.c helps analysis centered on eliminating breast most cancers disparities;
“We nonetheless have a lot to study aggressive breast cancers and breast cancers that recur and metastasize. This crucial analysis funding from Susan G. Komen will assist us unravel the biology of breast cancers to higher perceive the best way to stop breast most cancers recurrence and metastasis, and develop extra therapy choices, together with new remedies for individuals dwelling with metastatic breast most cancers,” stated Jennifer Pietenpol, Ph.D., Susan G. Komen Chief Scientific Advisor.
Pietenpol additionally serves because the Benjamin F. Byrd, Jr. Professor of Oncology, Chief Scientific and Technique Officer and Govt Vice President for Analysis at Vanderbilt College Medical Heart.
Komen analysis grants are being awarded to the next examine investigators at 26 preeminent U.S. establishments:
Julie Palmer, Sc.D., M.P.H., Boston College
Jennifer Ligibel, M.D., FASCO, Dana-Farber Most cancers Institute
Nancy Lin, M.D., Dana-Farber Most cancers Institute
Kornelia Polyak, M.D., Ph.D., Dana-Farber Most cancers Institute
Sara Tolaney, M.D., M.P.H., Dana-Farber Most cancers Institute
Nikhil Wagle, M.D., Dana-Farber Most cancers Institute
Sunil Badve, M.D., FRCPath, Emory College College of Drugs
Maria Sosa, Ph.D., Icahn College of Drugs at Mount Sinai
Tarah Ballinger, M.D., Indiana College
Pedram Razavi, M.D., Ph.D., Memorial Sloan Kettering Most cancers Heart
Jorge Reis-Filho, M.D., Ph.D., FRCPath, Memorial Sloan Kettering Most cancers Heart
Sohrab Shah, Ph.D., Memorial Sloan Kettering Most cancers Heart
Lisa Coussens, Ph.D., Oregon Well being & Science College
Yibin Kang, Ph.D., Princeton College
Hai Wang, Ph.D., Roswell Park Most cancers Institute
Christina Curtis, Ph.D., M.S., Stanford College College of Drugs
Melinda Telli, M.D., Stanford College College of Drugs
Allison Kurian, M.D., M.Sc., Stanford College College of Drugs
Haruka Itakura, M.D., Ph.D., Stanford College College of Drugs
Daniel Hollern, Ph.D., The Salk Institute for Organic Research
Reshma Jagsi, M.D., D.Phil., College of Michigan
Melissa Troester, Ph.D., College of North Carolina at Chapel Hill
Angela DeMichele, M.D., M.S.C.E., College of Pennsylvania
Adrian Lee, Ph.D., College of Pittsburgh
Steffi Oesterreich, Ph.D., College of Pittsburgh
Alana Welm, Ph.D., College of Utah Huntsman Most cancers Institute
Amelie Ramirez, Dr.P.H., M.P.H., UT Well being San Antonio
Mariana Chavez MacGregor, M.D., M.Sc., FASCO, UT M.D. Anderson Most cancers Heart
Sharon Giordano, M.D., M.P.H., FASCO, UT M.D. Anderson Most cancers Heart
Srinivas Malladi, Ph.D., UT Southwestern Medical Heart
Tuya Pal, M.D., Vanderbilt College Medical Heart
Ben Ho Park, M.D., Ph.D., Vanderbilt College Medical Heart
Jennifer Pietenpol, Ph.D., Vanderbilt College Medical Heart
Sonya Reid, M.D., Ph.D., Vanderbilt College Medical Heart
Cynthia Ma, M.D., Ph.D., Washington College
Rulla Tamini, Sc.D., Weill Cornell Faculty of Cornell College
Mariya Rozenblit, M.D., Yale College
Lajos Pusztai, M.D., D.Phil., Yale College
Komen has invested greater than $1 billion in breast most cancers analysis within the 40 years since its founding, greater than every other non-profit, and second solely to the U.S. authorities.
